S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Warning: Biden’s Big Blackout is Coming (Ad)
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Warning: Biden’s Big Blackout is Coming (Ad)
TG Therapeutics Stock 300% Rally Has Legs Yet
Daqo New Energy Charged Up For New Highs
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Warning: Biden’s Big Blackout is Coming (Ad)
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Warning: Biden’s Big Blackout is Coming (Ad)
TG Therapeutics Stock 300% Rally Has Legs Yet
Daqo New Energy Charged Up For New Highs
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Warning: Biden’s Big Blackout is Coming (Ad)
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Warning: Biden’s Big Blackout is Coming (Ad)
TG Therapeutics Stock 300% Rally Has Legs Yet
Daqo New Energy Charged Up For New Highs
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Warning: Biden’s Big Blackout is Coming (Ad)
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Warning: Biden’s Big Blackout is Coming (Ad)
TG Therapeutics Stock 300% Rally Has Legs Yet
Daqo New Energy Charged Up For New Highs
NASDAQ:ALEC

Alector - ALEC Stock Forecast, Price & News

$9.36
-0.38 (-3.90%)
(As of 02/8/2023 12:00 AM ET)
Add
Compare
Today's Range
$9.27
$9.74
50-Day Range
$8.11
$9.74
52-Week Range
$6.84
$17.68
Volume
519,684 shs
Average Volume
593,361 shs
Market Capitalization
$774.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.75

Alector MarketRank™ Forecast

Analyst Rating
Hold
2.29 Rating Score
Upside/​Downside
79.0% Upside
$16.75 Price Target
Short Interest
Bearish
7.86% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.92
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.43) to ($1.39) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.15 out of 5 stars

Medical Sector

408th out of 1,026 stocks

Biological Products, Except Diagnostic Industry

66th out of 167 stocks

ALEC stock logo

About Alector (NASDAQ:ALEC) Stock

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Receive ALEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alector and its competitors with MarketBeat's FREE daily newsletter.

ALEC Stock News Headlines

Dividend Expert Reveals His Biggest Income Secrets… Free of Charge
Marc Lichtenfeld –Author of the best-selling book Get Rich With Dividends – is giving away his Ultimate Dividend Package… Get His #1 Dividend Stock… The Safest 9% Dividend in the World… Top Three “Extreme Dividend” Stocks, And Much, Much More
Alector Third Quarter 2022 Earnings: Misses Expectations
Dividend Expert Reveals His Biggest Income Secrets… Free of Charge
Marc Lichtenfeld –Author of the best-selling book Get Rich With Dividends – is giving away his Ultimate Dividend Package… Get His #1 Dividend Stock… The Safest 9% Dividend in the World… Top Three “Extreme Dividend” Stocks, And Much, Much More
Morgan Stanley Downgrades Alector: Here's What You Need To Know
See More Headlines
Receive ALEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alector and its competitors with MarketBeat's FREE daily newsletter.

ALEC Company Calendar

Last Earnings
11/04/2021
Today
2/09/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ALEC
Fax
N/A
Employees
208
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$16.75
High Stock Price Forecast
$41.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+79.0%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
7 Analysts

Profitability

Net Income
$-36,330,000.00
Net Margins
-102.49%
Pretax Margin
-100.59%

Debt

Sales & Book Value

Annual Sales
$207.09 million
Book Value
$3.70 per share

Miscellaneous

Free Float
72,042,000
Market Cap
$774.07 million
Optionable
Not Optionable
Beta
0.83

Key Executives

  • Arnon RosenthalArnon Rosenthal
    Chief Executive Officer & Director
  • Saraswati Kenkare-Mitra
    President, Head-Research & Development
  • Marc Edward Grasso
    Chief Financial, Accounting & Business Officer
  • Charles Wolfus
    VP-Technology & Digital Health
  • Gary Romano
    Chief Medical Officer













ALEC Stock - Frequently Asked Questions

Should I buy or sell Alector stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alector in the last year. There are currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ALEC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALEC, but not buy additional shares or sell existing shares.
View ALEC analyst ratings
or view top-rated stocks.

What is Alector's stock price forecast for 2023?

7 brokers have issued twelve-month price objectives for Alector's stock. Their ALEC share price forecasts range from $6.00 to $41.00. On average, they predict the company's share price to reach $16.75 in the next year. This suggests a possible upside of 79.0% from the stock's current price.
View analysts price targets for ALEC
or view top-rated stocks among Wall Street analysts.

How have ALEC shares performed in 2023?

Alector's stock was trading at $9.23 on January 1st, 2023. Since then, ALEC stock has increased by 1.4% and is now trading at $9.36.
View the best growth stocks for 2023 here
.

When is Alector's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our ALEC earnings forecast
.

How were Alector's earnings last quarter?

Alector, Inc. (NASDAQ:ALEC) announced its quarterly earnings data on Thursday, November, 4th. The company reported $1.49 earnings per share for the quarter, topping the consensus estimate of ($0.46) by $1.95. The business earned $182.41 million during the quarter, compared to the consensus estimate of $407.41 million. Alector had a negative trailing twelve-month return on equity of 49.19% and a negative net margin of 102.49%.

What is Arnon Rosenthal's approval rating as Alector's CEO?

4 employees have rated Alector Chief Executive Officer Arnon Rosenthal on Glassdoor.com. Arnon Rosenthal has an approval rating of 100% among the company's employees. This puts Arnon Rosenthal in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Alector own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alector investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD), Gossamer Bio (GOSS), Kaleido Biosciences (KLDO), QUALCOMM (QCOM), Intel (INTC), Micron Technology (MU) and Cisco Systems (CSCO).

When did Alector IPO?

(ALEC) raised $177 million in an initial public offering on Thursday, February 7th 2019. The company issued 9,300,000 shares at $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO.

What is Alector's stock symbol?

Alector trades on the NASDAQ under the ticker symbol "ALEC."

Who are Alector's major shareholders?

Alector's stock is owned by many different retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (0.47%), Los Angeles Capital Management LLC (0.30%), Nordea Investment Management AB (0.21%), UBS Group AG (0.20%), Swiss National Bank (0.16%) and Russell Investments Group Ltd. (0.14%). Insiders that own company stock include Arnon Rosenthal, Calvin Yu, Orbimed Advisors Llc, Richard H Scheller, Robert King, Robert Paul, Shehnaaz Suliman and Terrance Mcguire.
View institutional ownership trends
.

How do I buy shares of Alector?

Shares of ALEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alector's stock price today?

One share of ALEC stock can currently be purchased for approximately $9.36.

How much money does Alector make?

Alector (NASDAQ:ALEC) has a market capitalization of $774.07 million and generates $207.09 million in revenue each year. The company earns $-36,330,000.00 in net income (profit) each year or ($1.66) on an earnings per share basis.

How many employees does Alector have?

The company employs 208 workers across the globe.

How can I contact Alector?

Alector's mailing address is 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.alector.com. The company can be reached via phone at (415) 231-5660 or via email at ir@alector.com.

This page (NASDAQ:ALEC) was last updated on 2/9/2023 by MarketBeat.com Staff